Quarterly Period Covered: Q2 2026 (April 4 - July 3, 2026) with year-to-date results through July 3, 2026 Company Information: Veralto Corp is an industrial instruments and testing company (SIC 3825) headquartered in Waltham, Massachusetts, with fiscal year ending December 31 Financial Statements Included: The filing contains consolidated balance sheets, statements of operations, statements of…

Our analysis rates this filing CAUTIOUS. Veralto Corp presents an elevated but manageable concern profile driven primarily by acquisition integration execution risk rather than fundamental business deterioration. The completion of two acquisitions within a compressed 6-month timeframe (January and…

Concern level: ELEVATED (5.8/10). Key factors: Two significant acquisitions completed within 6-month window (In Situ Inc in January 2026, Global Vision in April 2026) introducing material integration execution risk; Recent acquisition of Global Vision only 3 months prior to filing date, providing minimal integration track record and elevated near-term execution uncertainty; Substantial intangible…

Notable risk changes: Two significant acquisitions completed in H1 2026 (In Situ Inc in January, Global Vision in April) expanding Water Quality and Product Quality segments - integration execution risk introduced; Expanded geographic and segment reporting structure reflects acquisition-driven portfolio changes, with new segment combinations for North America, Western Europe, Other Developed Markets, and High Growth…

The model predicts VLTO will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.